Rosarium Health Secures $6M for Senior Care Marketplace
Rosarium Health has secured $6 million in seed funding to expand its platform for in-home care modifications. The round was led by Kalos Ventures, with additional support from ResilienceVC, Rock Health Capital, and other investors. The company focuses on helping seniors stay in their homes through tailored renovations and clinical guidance.
Targeting Medicaid and Medicare Recipients
The firm is in-network for 1.2 million Medicaid and Medicare beneficiaries. Funds will build a national network connecting service providers with individuals, insurers, and non-profits. This includes clinical teams that recommend home modifications and oversee installations.
Home modifications are a growing need as aging populations seek alternatives to nursing homes. They combine technology with hands-on services to address physical barriers in homes. The company emphasizes partnerships with local contractors and healthcare professionals.
Other Investment Highlights
Sychedelic, a neurotech firm, closed a $3.5 million seed round led by Cultadvisors LLP. It is developing closed-loop neurostimulation headphones that use tDCS, binaural audio, and HRV biofeedback to aid sleep and relaxation. Funds will support product development and global expansion.
The technology aims to help users manage stress through real-time physiological data. It plans to integrate AI into wellness systems, though specifics remain limited. Sychedelic has not disclosed plans for clinical trials or regulatory approvals.
Focus on Rural Preventative Care
Paralign Health raised $3 million led by Flyover Capital. The Kansas City-based startup helps health plans identify high-risk patients in rural areas and connect them with local EMS teams for in-home care. The model relies on existing trust in emergency services.
Patrick Berry of Flyover Capital called rural EMS agencies “trusted assets” that can deliver scalable care. Paralign’s platform uses data analytics to flag at-risk individuals and coordinate preventive visits. The company has not yet released metrics on its pilot programs.
Each firm’s funding reflects growing interest in tech-driven healthcare solutions. Rosarium’s focus on home modifications aligns with broader trends in aging-in-place initiatives. Sychedelic’s neurostimulation devices target a niche but expanding market for consumer wellness tech, similar to companies like Oura, which has filed for an initial public offering.
Investors in all three rounds include firms with ties to healthcare innovation. Kalos Ventures, for example, has previously backed telemedicine startups. Flyover Capital’s involvement in Paralign highlights its focus on rural health access. These investments may signal shifting priorities in healthcare venture capital.
None of the companies have disclosed immediate plans for profitability. Rosarium and Paralign emphasize scaling networks, while Sychedelic aims to refine its product before wider distribution. Regulatory hurdles, particularly for Sychedelic’s devices, remain unaddressed in public statements.
The funding rounds occur amid debates over healthcare cost containment and accessibility. Home modifications and preventive care models are seen as potential cost-saving measures by some insurers. However, critics question the long-term viability of these approaches without strong reimbursement policies, according to the report.
